Gynaecology oncology screening
Gynaecology oncology screening: Early detection, protection of women ‘ s health
Gynaecological neoplasms are serious diseases common to women and concern several parts of the uterus, ovaries, cervix and vagina. With the development of modern medical technology, many gynaecology tumours can be effectively detected at an early stage through screening, thus increasing the success of treatment and the survival of patients. The screening of gynaecology oncology is therefore particularly important. This paper presents the common types of gynaecology tumours, the methods of screening and their importance, and helps women to better understand and prevent gynaecological tumours.
I. Common types of gynaecological tumours
Cervical cancer
Cervical cancer is one of the most common malignant neoplasms in women. This is mainly due to changes in cervical epipelagic cells caused by the chronic human papilloma virus (HPV). The early stages of cervical cancer are usually free of visible symptoms, such as when they are visible, they are often in the middle and late stages. Early screening for cervical cancer is therefore particularly important.
2. ovarian cancer
The cancer of ovarians is an invasive tumor with less visible early symptoms, commonly known as the “silent killer”. The incidence of ovarian cancer increases with age, especially among post-menopausal women. Although early screening for ovarian cancer is difficult, high-risk patients can still be identified through a number of tests.
3. Endeminal uterine cancer
Endouterine cancer is a common malignant tumour in the female reproductive system and is usually associated with changes in hormone levels (e.g., excessive long-term estrogen levels). The common symptoms are abnormal vaginal bleeding, especially among post-menopausal women. If detected at an early stage, the effects of the treatment will be greatly enhanced.
4. Cervical musculoma
Although uterus tumours are generally considered to be benign tumours, their growth in size or location at that time can affect women ‘ s fertility or cause other complications. Regular screening is therefore essential for the early detection and treatment of uterus membrane.
Importance of gynaecology tumour screening
Early gynaecology tumours are usually not visible or similar to other diseases, so many women are not detected at the early stages of the disease. Through regular screening, diseases can be detected early enough to avoid further development. Early detection of gynaecology tumours not only increases the cure rate, but also reduces treatment costs and post-treatment complications and reduces the suffering of patients.
Screening is particularly important for high-risk groups, such as women with family history, long-term exposure to carcinogenic substances, hormone-level disorders, etc. Through screening, doctors can identify potential risks for these groups and provide appropriate intervention or treatment.
III. Method of screening for gynaecology tumours
Cervical cancer screening
Cervical cancer screening is based on the following methods:
Cervical cytology (Pap smear): Cervical smear is the regular method of screening for cervical cancer, which can be detected at an early stage through cytological changes on the cervix surface.
HPV: The human papilloma virus (HPV) is the main cause of cervical cancer. HPV testing can detect high-risk HPV infections and help screen for cervical cancer. In recent years, HPV testing has become an important complement to cervical cancer screening.
Vagina lenses: For patients with cervical cytology tests or HPV detection abnormalities, doctors may recommend further vaginal lenses to see if there is a disease on the cervix surface.
2. Screening for ovarian cancer
Screening for ovarian cancer is relatively complex and there is currently no generally recommended screening method. Common methods of ovarian cancer screening include:
Ultrasound: The size, shape and presence of abnormal swelling can be observed through vaginal ultrasound. Ultrasound is an important screening tool for women with symptoms or high-risk groups.
Oncological marker CA-125: CA-125 is a tumour marker common in ovarian cancer, which, although low in sensitivity and specificity, can be used as an aid for ovarian cancer screening, especially among high-risk patients with known ovarian disease.
3. Screening for uterine membrane cancer
Intrauterine cancer screening methods typically include:
Through vaginal ultrasound: the thickness of the uterine membrane can be observed by ultrasound. Under normal circumstances, the female uterine membrane following menopause should be thinner. If an ultrasound examination reveals an abnormal increase in the endomelet, the doctor may recommend further examination.
Endometriosis: If an ultrasound examination reveals an anomaly, the doctor may perform an endometriosis examination to check for cancer in the cell by sampling.
4. Screening for uterine membrane
The screening of uterine membrane relies mainly on ultrasound. Ultrasound can accurately assess the size, location and risk of symptoms. If a uterus tumour is found to be large or if symptoms occur, the doctor may recommend further treatment.
IV. How to participate in gynaecology tumour screening
Periodic medical check-ups: Women should undergo regular gynaecological examinations in accordance with their age and state of health, especially if they are over 20 years of age. It is generally recommended that a regular gynaecology check-up be conducted annually, including cervical cytology (Pap smear) and HPV.
Understanding high-risk factors: If you have high-risk factors such as family history, long-term hormonal drug use, obesity, early marriage and early childbearing, there should be a discussion with doctors about the need for enhanced screening.
Attention to physical changes: Women should be aware of any abnormal symptoms of the body, such as abnormal vaginal bleeding, persistent abdominal pain, abdominal pain, reduced appetite, etc., and should be treated in a timely manner.
Concluding remarks
Screening for gynaecological tumours is essential for women ‘ s health, and regular screening not only detects problems at an early stage, but also greatly improves treatment. Women should be made more aware of their health, develop a good habit of regular medical examinations, and protect their health effectively by early identification and prevention of potential cancer risks.
